DXOCRO

Oxford, United States Founded: 2017 • Age: 9 yrs
Provides in vitro diagnostic services for oncology research and development.
Request Access

About DXOCRO

DXOCRO is a company based in Oxford (United States) founded in 2017. It operates as a B2B. DXOCRO offers products and services including In Vitro Diagnostics Services. DXOCRO operates in a competitive market with competitors including Redbud Medicine, OncoTheis, AlphaVax, Ontogen and RecurX Bio, among others.

  • Headquarter Oxford, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name Diagnostic Oncology Cro, Inc.
Operational Areas
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of DXOCRO

DXOCRO offers a comprehensive portfolio of products and services, including In Vitro Diagnostics Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Services for in vitro testing in oncology research and development.

Funding Insights of DXOCRO

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by DXOCRO

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - DXOCRO

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Dxocro Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of DXOCRO

DXOCRO operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Redbud Medicine, OncoTheis, AlphaVax, Ontogen and RecurX Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Offers comprehensive services in regulatory affairs, R&D, data management, and statistical analysis for healthcare.
domain founded_year HQ Location
Provides 3D tissue testing services for in-vitro lung cancer drug testing.
domain founded_year HQ Location
Vaccines for infectious diseases and cancer immunotherapy are developed.
domain founded_year HQ Location
AI-based knowledge management platform for enterprises
domain founded_year HQ Location
Delivers comprehensive preclinical services for oncology drug development.
domain founded_year HQ Location
A biotechnology company developing autologous immune cell therapies to treat various types of cancer.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Dxocro

Frequently Asked Questions about DXOCRO

When was DXOCRO founded?

DXOCRO was founded in 2017.

Where is DXOCRO located?

DXOCRO is headquartered in Oxford, United States.

What does DXOCRO do?

Diagnostic Oncology CRO, LLC is a contract research organization based in Oxford, Connecticut, United States. It specializes in in vitro diagnostics, offering solutions for clinical laboratories and healthcare sectors. The company supports diagnostic development and research activities, focusing on oncology applications to assist pharmaceutical and medical clients.

Who are the top competitors of DXOCRO?

DXOCRO's top competitors include Ontogen, AlphaVax and Redbud Medicine.

What products or services does DXOCRO offer?

DXOCRO offers In Vitro Diagnostics Services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available